The Public Health Role in Translating Advances in Genomics

August 13, 2014
The Public Health Role in Translating Advances in Genomics
Each year millions of babies are routinely screened for certain genetic, endocrine, and metabolic disorders, often using a point-of-care test at the bedside. [© millaf –]

Muin J. Khoury, M.D., Ph.D.

Scott Bowen

Thirteen years after the completion of the Human Genome Project, an increasing number of genomic applications, including next-generation sequencing (NGS), are poised for clinical use. Fulfilling the promise of genomics to improve health in the real world requires a public health perspective.

As genomics reaches the bedside, a public health “post bedside” research agenda will be able to assess the contribution of genomics and other new markers to health and disease in the larger social and environmental context, evaluate promising genomic technologies for their potential to improve health and healthcare, design appropriate strategies for integrating genomics into clinical and public health practice and ensuring access, and continuously measure population health impact of these new technologies. 

For the rest of the story, click here.


Oops! Please type your email in the following format: [email protected]

You’re all set!
Thank you for subscribing to
Clinical OMICs Weekly